Skip to content
‹ Back to IndustriesHealthcare

Creating Production Standards in the CBD Industry

You may have noticed the surge of CBD products on shelves near you. Whether it’s at your local pharmacy, drug store, or even coffee shop, CBD is popping up everywhere in lotions, lattes, gummies, and oils. But how healthy is it, and what sort of quality and production standards are being set? Here to…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

You may have noticed the surge of CBD products on shelves near you. Whether it’s at your local pharmacy, drug store, or even coffee shop, CBD is popping up everywhere in lotions, lattes, gummies, and oils. But how healthy is it, and what sort of quality and production standards are being set?

Here to answer our burning questions about this burgeoning industry on today’s Food & Beverage podcast is Kate Kinnison, vice president of sales and owner of RAD Extracts, a Colorado based B2B CBD supplier.

CBD (short for cannabidiol), is most commonly derived from the hemp plant. Hemp has gotten a bad rap because of its cousin, the marijuana plant, known to contain the psychoactive compound THC. But marijuana and hemp share another compound—CBD, which is completely legal and has shown positive health benefits in initial studies.

Kinnison explained how there’s more to CBD than just the compound itself. RAD Extracts looks at the hemp plant’s benefits holistically, utilizing all of hemp’s cannabinoids to create a product with the utmost benefit.

It comes down to, “All of those compounds in that plant working together in a synergistic feature, to really have the maximum benefits for individuals who are using it,” Kinnison said.

CBD is still rather unregulated, with no guarantee of the quality, purity, or efficacy of what’s hitting shelves. RAD Extracts aims to be ahead of the game, exercising the highest quality practices in their production to produce full-spectrum CBD, not a less-potent distillate.

“By creating a premium full spectrum product we really feel like we’re doing the plant justice,” Kinnison said.

So who could benefit from CBD?

“The amount of different applications it has is amazing,” Kinnison said, with some patients reporting it helping with conditions as varied as acute pain, chronic pain, epilepsy, anxiety, Alzheimers, and even acne.

The future of CBD is still unsure, but Kinnison projected that hemp’s popularity will increase as studies continue to come out touting the benefits of CBD.

For the latest news, videos, and podcasts in the Food & Beverage Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @FoodMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

On I Don’t Care, BedConnect founder Lindsey Joseph and Kevin Stevenson discuss the limits of broad post-acute referrals. Their proposal is to match clinical needs, payer coverage and available beds before presenting options. CMS guidance and AHRQ discharge resources provide independent context; they do not establish BedConnect’s clinical outcomes.

  • 01BedConnect proposes matching clinical needs, payer coverage and bed availability before presenting post-acute options; this is the company’s approach, not independently validated outcome evidence.
  • 02CMS discharge-planning guidance emphasizes patient goals, treatment preferences and relevant provider quality and resource-use data.
  • 03Readmission comparisons need a defined patient group, time window and source; the interview’s roughly one-quarter/fourteen-day estimate has not been independently verified.

Sep 29, 2026

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: U.S. digital health startups raised $7.4 billion across 244 deals in H1 2026, up from $6.4 billion on 245 deals in H1 2025. The rebound is concentrated. Nineteen companies raised 20 $100 million-plus rounds that captured 45% of capital.

  • 01In H1 2026, 19 companies raised 20 mega-deals of $100 million or more, representing 45% of all capital invested, according to Rock Health.
  • 02According to Rock Health, the firm stopped labeling startups as “AI-enabled,” saying the technology is now too widespread for the label to be meaningful.

Sep 24, 2026

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Medicare will pay up to $137.53 per case in 2027 for BriefCase‑Triage

Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage. Holland & Knight said hospitals will be eligible for NTAP reimbursement for use of Aidoc’s CARE Body CT Multi-Triage beginning Oct. 1, 2026, with supplemental payments continuing for three years.

  • 01Radiology Business reported Medicare will pay a maximum of $137.53 per case in 2027 for BriefCase-Triage.
  • 02Holland & Knight said CMS approved an NTAP designation for Aidoc’s CARE Body CT Multi-Triage, with hospitals eligible for NTAP reimbursement beginning Oct. 1, 2026, with supplemental payments continuing for three years.

Sep 23, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512